Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. [electronic resource]
- Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis Jul 2003
- 469-77 p. digital
Publication Type: Journal Article
0957-5235
10.1097/00001721-200307000-00007 doi
Adult Aged Aged, 80 and over Anticoagulants--adverse effects Blood Coagulation--drug effects Cerebral Hemorrhage--chemically induced Computer Systems Drug Evaluation Factor VII--pharmacology Factor VIIa Female Hematoma--chemically induced Hemostatics--pharmacology Humans International Normalized Ratio Male Middle Aged Recombinant Proteins--pharmacology Thrombelastography Thromboembolism--prevention & control Treatment Outcome Vitamin K--antagonists & inhibitors Warfarin--adverse effects